A Phase 2 Clinical Study of Ziftomenib in Patients With Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Ziftomenib
Related studies linked through entity extraction aliases.
Phase 1/1b Trial Of Olutasidenib And Ziftomenib For NPM1 And IDH1 Co-Mutated Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- Status
- RECRUITING
- Phase
- PHASE3
Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase I Study Investigating the Combination of the Menin Inhibitor Ziftomenib With Venetoclax and Gemtuzumab in Pediatric Patients With Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Expanded Access to Ziftomenib
- Status
- AVAILABLE
- Phase
- N/A